A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Clinical trial NCT02057159 · UNKNOWN
Trial details
- NCT number
- NCT02057159
- Sponsor
- Immune Response BioPharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-09
- Primary completion
- 2023-03-09
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.